An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region

BACKGROUND: American Cutaneous Leishmaniasis (ACL), a vector borne disease, is caused by various species of Leishmania and in the Amazonas, Leishmania guyanensis is predominant. The recommended drugs for treatment of cutaneous leishmaniasis (CL) in Brazil are pentavalent antimonials, pentamidine ise...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS Negl Trop Dis
Autors principals: Gadelha, Ellen Priscilla Nunes, Ramasawmy, Rajendranath, da Costa Oliveira, Bruna, Morais Rocha, Nágila, de Oliveira Guerra, Jorge Augusto, Allan Villa Rouco da Silva, George, Gabrielle Ramos de Mesquita, Tirza, Chrusciak Talhari Cortez, Carolina, Chrusciak Talhari, Anette
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6231690/
https://ncbi.nlm.nih.gov/pubmed/30379814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006850
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars